Possibilities of artificial intelligence in the development of antihypertensive herbal preparations

2025

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.59598/me-2305-6053-2025-114-1-137-140
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In the modern pharmaceutical industry, the application of artificial intelligence significantly enhances the process of drug development. Recent studies have revealed that artificial intelligence can notably improve the effectiveness of hypertension treatment by optimizing the compositions of herbal blends. This study proposes three unique formulations of blends developed using the ChatGPT neural network. The three devised blend compositions are formulated based on the analysis of plant data, their interactions, and treatment effectiveness. Each composition is meticulously selected to ensure maximum efficacy and minimal side effects. These innovative approaches have the potential to significantly enhance patients' quality of life by providing them with more effective and safer means for treating hypertension and other cardiovascular conditions. This progress opens up new perspectives for future medical development, emphasizing the significance of the symbiosis between technology and medical practice.